Live

Trump, Biden clash in final debate on COVID-19 response, health care, race

Highlights from the final presidential debate before Election Day.

Last Updated: November 3, 2020, 9:12 AM EST

President Donald Trump and former Vice President Joe Biden, the Democratic nominee, faced off in the final presidential debate of the 2020 election cycle from Belmont University in Nashville on Thursday night, marking the candidates’ last chance to pitch themselves to tens of millions of voters in primetime before Nov. 3.

The stakes were high: Trump needed to make his case as polls show him trailing nationally and in several battleground states key to his reelection hopes. At the same time, Biden had a platform to solidify his lead and avoid any major mistakes with Election Day just 12 days away.

Biden spent the week hunkered down in Wilmington, Delaware, to prepare -- what he's done before other debates -- while Trump had seemingly done less to prepare, telling reporters on Wednesday, "I do prep, I do prep," without elaborating. Earlier this week Trump said that answering journalists' questions is the best kind of preparation.

Thursday's debate was supposed to be the candidates' third matchup but is instead the second of only two presidential debates this election. Trump refused to participate in the second debate when it was moved to a virtual format following his COVID-19 diagnosis. The candidates ultimately participated in dueling town halls instead.

Top headlines:

Here's how the evening unfolded. All times Eastern.
Oct 22, 2020, 11:17 PM EDT

Fact check: Trump calls COVID-19 antibody treatment a 'cure.' It's not. 

TRUMP'S CLAIM: "And I will tell you that I had something that they gave me, a therapeutic, I guess they would call it, some people could say it was a cure. But I was in for a short period of time and I got better very fast or I wouldn't be here tonight."

FACT CHECK: Trump also repeated something he has said before, praising the antibody treatment he received a "cure."

But as of yet, there is no known "cure" for the novel coronavirus.

The antibody cocktail given to the president -- made by biotech company Regeneron -- is thought to be promising, though still in its experimental phase.

Regeneron's experimental treatment is a cocktail of two synthetic, pharmaceutical versions of what occurs naturally in the body to fight off infection. Late last month, Regeneron published positive, yet preliminary data for its cocktail treatment showing it improved symptoms in patients without severe disease.

While the Food and Drug Administration has not yet authorized it, Trump was granted access to it under "compassionate use," enabling him to get it outside of a clinical trial.

A Regeneron spokesperson confirmed to ABC News that Trump's medical staff reached out to the company for permission to use its monoclonal cocktail, and that it was cleared with the FDA.

-ABC News' Sony Salzman and Sasha Pezenik

Oct 22, 2020, 11:12 PM EDT

Fact check: Trump falsely claims that kids aren't transmitting virus to teachers

TRUMP'S CLAIM: "I want to open the schools. The transmittal rate to the teachers is very small." 

FACT CHECK: The Centers for Disease Control and Prevention has updated its guidance to note a "body of evidence is growing" that kids "might play a role in transmission." Still, the role children play in community transmission is not yet fully understood. 

In one recent study, the CDC found transmission is unclear: "Recent evidence suggests that children likely have the same or higher viral loads in their nasopharynx compared with adults and that children can spread the virus effectively in households and camp settings."

Schools haven't been studied as closely because many remain closed and not every school is reporting outbreaks. One concern is that children might be transmitting the virus without exhibiting symptoms, and testing people without symptoms remains limited.

Overall, officials say the lower transmission levels in a community, the less likely schools will spread the virus.

-ABC News' Anne Flaherty

Oct 22, 2020, 10:59 PM EDT

Fact Check: Trump overstates vaccine readiness timeline  

TRUMP'S CLAIM: "We have a vaccine that's coming. It's ready. It's going to be announced within weeks. And it's going to be delivered." ... "Johnson & Johnson is doing very well. Moderna is doing very well. Pfizer is doing very well. And we have numerous others."

FACT CHECK: A COVID-19 vaccine isn't ready right now. But it is true that two companies -- Pfizer and Moderna -- could seek emergency use authorization in November or December.

Like Pfizer and Moderna, Johnson & Johnson's vaccine is also in late-stage studies, but Johnson & Johnson paused its trial earlier this month to investigate an unexplained illness. 

As the chief adviser to the government vaccine distribution initiative Operation Warp Speed, Dr. Moncef Slaoui told ABC’s Bob Woodruff this week that if a vaccine is authorized before the end of the year approximately 20 million to 40 million doses of it will be stockpiled and ready for distribution for a limited population. At first, only high priority Americans, like those over 65, will have access, but by the springtime more Americans should have access.

Slaoui said that vaccine trials are going as fast as it’s safe to go, pledging to resign if he felt undue pressure from the White House. Slaoui said that by June 2021, it's possible "everybody" in the United States could have been immunized.

-ABC News' Sony Salzman and Sasha Pezenik

Oct 22, 2020, 10:49 PM EDT

Fact check: Trump misleads on fundraising

TRUMP'S CLAIM: “Joe, you have raised a lot of money, tremendous amounts of money and every time you raise money, deals are made, Joe. I could raise so much more money as president and as somebody that knows most of those people. I could call the heads of Wall Street, the heads of every company in America. I would blow away every record, but I don't want to do that because it puts me in a bad position.”

FACT CHECK: Trump targeted Biden for raising money for his campaign by claiming he could raise more but would be put in a “bad position” because he would owe donors something in return.

However, Trump himself regularly holds private, high-dollar fundraisers raking in millions of dollars and has raised over $1.5 billion so far this election cycle.

Just a week ago, the president attended a closed-door fundraiser at the home of Nicole and Palmer Luckey, an entrepreneur -- where tickets ranged from $2,800 up to $100,000 per person.

-ABC News' Will Steakin